Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial.
Saved in:
| Title: | Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial. |
|---|---|
| Authors: | Bauer, Katrin I.1,2,3 (AUTHOR), Baker, Dhanwin4 (AUTHOR), Lerner, Raissa4 (AUTHOR), Koeck, Thomas2,3 (AUTHOR), Buch, Gregor2,3,5 (AUTHOR), Fischer, Zlatka2,3,5 (AUTHOR), Martens, Robin2 (AUTHOR), Esenkova, Ekaterina E.1,2,3 (AUTHOR), Nuber, Maximilian1,2,3 (AUTHOR), Andrade-Navarro, Miguel A.6 (AUTHOR), ten Cate, Vincent2,3,7 (AUTHOR), Tenzer, Stefan8 (AUTHOR), Wild, Philipp S.2,3,9,10 (AUTHOR), Bindila, Laura4 (AUTHOR), Araldi, Elisa1,2,3,11 (AUTHOR) araldiel@uni-mainz.de |
| Source: | Cardiovascular Diabetology. 9/8/2025, Vol. 24 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!